إعلان
إعلان
CTMX
CytomX Therapeutics, Inc.
4.33
USDبرعاية
+0.08
+1.76%
٠٩ يناير, ١٥:٥٩ UTC -5
مغلق
بعد الإغلاق
4.38
+0.04
+0.92%
تقارير أرباح CTMX
النسبة الإيجابية المفاجئة
CTMX تفوق 23 من 40 آخر التقديرات.
57%
التقرير التالي
بيانات التقرير القادم
٠٤ مارس ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
$8.30M
/-$0.06
التغير الضمني من Q3 25 (Revenue/ EPS)
+39.20%
/-33.33%
التغير الضمني من Q4 24 (Revenue/ EPS)
-78.21%
/-126.09%
CytomX Therapeutics, Inc. earnings per share and revenue
On ٠٦ نوفمبر ٢٠٢٥, CTMX reported earnings of -0.09 USD per share (EPS) for Q3 25, missing the estimate of -0.05 USD, resulting in a -74.42% surprise. Revenue reached 5.96 مليون, compared to an expected 11.86 مليون, with a -49.71% difference. The market reacted with a -13.60% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 10 المحللين forecast an EPS of -0.06 USD, with revenue projected to reach 8.30 مليون USD, implying an نقصان of -33.33% EPS, and زيادة of 39.20% in Revenue from the last quarter.
الأسئلة الشائعة
What were CytomX Therapeutics, Inc.'s earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, CytomX Therapeutics, Inc. reported EPS of -$0.09, missing estimates by -74.42%, and revenue of $5.96M, -49.71% below expectations.
How did the market react to CytomX Therapeutics, Inc.'s Q3 2025 earnings?
The stock price moved down -13.6%, changed from $4.19 before the earnings release to $3.62 the day after.
When is CytomX Therapeutics, Inc. expected to report next?
The next earning report is scheduled for ٠٤ مارس ٢٠٢٦.
What are the forecasts for CytomX Therapeutics, Inc.'s next earnings report?
Based on 10
المحللين, CytomX Therapeutics, Inc. is expected to report EPS of -$0.06 and revenue of $8.30M for Q4 2025.
Which companies are reporting earnings today?
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان